A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that combining pembrolizumab, ...
News Medical on MSN15h
New treatment combination improves outcomes for small cell bladder and prostate cancer patientsA research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...
The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.
Scientists also revealed that circular fragments of DNA called extrachromosomal DNA (ecDNA) is a significant source of drug ...
With the FDA's acceptance of Urogen's NDA and issuance of an 06/13/2025 PDUFA the clock is now ticking for FDA approval of ...
The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...
Around 10,500 people are diagnosed with bladder cancer annually in the UK, with approximately 20% of those having FGFR3 genetic alterations driving cancer growth. Professor Alison Birtle of Lancashire ...
The Hearty Soul on MSN23h
This ‘Silent' Cancer Symptom is Similar To Signs of a Common InfectionWhen it comes to cancer symptoms, we are often given advice on which signs to look out for. However, there is a type of ...
November is Bladder Health Month, and this year the Urology Care Foundation is focusing on flushing out the myths and ...
There are many causes of bladder cancer. Other risk factors besides smoking include chemicals ingested while working at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback